FDA 483 - Image Monitoring USA Inc. - February 06, 2020

An FDA inspection of Image Monitoring USA Inc. in Buffalo, NY, a medical device initial importer, revealed significant deficiencies in their quality management system. Observations included inadequate procedures for supplier quality management, insufficient document control practices, and a complete lack of documented personnel training records. These issues indicate a fundamental breakdown in maintaining compliance with regulatory requirements for medical device operations.